NHS cataract surgery and YAG laser capsulotomy patients will benefit from high-quality care and significantly reduced waiting times at new SpaMedica hospital.
With the 2006 Collaborative Ocular Melanoma Study Group (COMS) study demonstrating no difference in survival outcomes for participants randomised to either iodine-125 brachytherapy or enucleation, the majority of primary uveal melanomas in the United States are now treated with brachytherapy....
Sight Scotland, Sight Scotland Veterans and Visibility Scotland are delighted to announce that, in partnership with the Thomas Pocklington Trust, they are launching new Sight Loss Councils in Scotland.
The National Treatment Centre-Highland opened its doors to patients in April 2023. At a cost of £48 million this represented a significant investment by the Scottish Government for the provision of modern eye care for the North of Scotland.
National eye health survey shows a third of UK are considering laser eye surgery but vast majority are unaware it is non-reversible and how it can affect night vision.
BELKIN Vision, an innovator in ophthalmic medical solutions, is pleased to announce that the US Food and Drug Administration (FDA) has granted 510(k) clearance for its glaucoma laser, the Eagle device.